Thursday, April 3, 2025
HomePharma

Pharma

Pharma

Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate

Life Sciences Times - 0
Pharma

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19

Life Sciences Times - 0
Pharma

Next generation pharma glass: SCHOTT AG launches FIOLAX® Pro glass tubing

Life Sciences Times - 0
Pharma

OrsoBio to Present Phase 1 Data for the Liver-Targeted Mitochondrial Protonophore TLC-6740 in Development for the Treatment of Obesity at ObesityWeek® 2023

Life Sciences Times - 0
Pharma

TME Pharma Provides Positive Update on 18-Month Survival for NOX-A12 Combination Regimen in Brain Cancer and Provides Strategic Update Including Decision to Engage with...

Life Sciences Times - 0
Pharma

BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics

Life Sciences Times - 0
Pharma

BIOVECTRA Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (LNP) Delivery System Used in Manufacturing mRNA-Based Therapies

Life Sciences Times - 0
Pharma

Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable

Life Sciences Times - 0
Pharma

Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

Life Sciences Times - 0
Pharma

SCHOTT TOPPAC® freeze Wins Pharma Innovation Award

Life Sciences Times - 0
Pharma

Tris Pharma Secures First ex-US Authorizations for Quillivant ER Oral Suspension and Quillivant ER Chewable Tablet for the Treatment of Attention Deficit Hyperactivity Disorder

Life Sciences Times - 0
Pharma

Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas

Life Sciences Times - 0
1...789...61Page 8 of 61

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv